FindTrial
Sign In

Clinical study for early prediction and prognosis of refractory high thrombus burden

Clinical study for early prediction and prognosis of refractory high thrombus burden

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060750
Enrollment
Unknown
Registered
2022-06-09
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Refractory thrombus group:NA
Control group:NA

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with STEMI who underwent PPCI from December 2017 to December 2019.

Exclusion criteria

Exclusion criteria: History of surgery or trauma within 6 months, history of malignant tumor, active infection, renal failure and liver failure.

Design outcomes

Primary

MeasureTime frame
left ventricular ejection fraction;Major adverse cardiovascular events;—

Countries

China

Contacts

Public ContactYuquan He

China-Japan Union Hospital of Jilin University

heyq@jlu.edu.cn+86 13944145413

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026